Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sunniva Inc SNNVF

Sunniva Inc. is a Canada-based company. The Company is not engaged in any business.


GREY:SNNVF - Post by User

Post by Bluechip2on Apr 22, 2018 6:53am
347 Views
Post# 27922838

State of Affairs

State of Affairs
posted this on THCX board, as we were discussing the best US play in light of what is transpiring in the US MJ political landscape. Adding here for new or potential SNN investors, just a quick fact piece without opinions..... ok i got a couple of emails on this, so I will share my response as I've grown fond of this board. For the same reasons I picked THCX, Sunniva is the safest play. They have an LTA with Canopy for 90,000 kg over 2 years to fund their Oliver facility which breaks ground in a week or two. The high end strains will probably get them 7-8/gram in revenue. This facility will produce 100,000 kg/year beginning 1st quarter 2019. They own 8 NHS medical clinics with currently 96,000 medical cannabis patients in Canada. 25 per cent of the Oliver product is earmarked for these clinics at premium margins. So effectively, the Oliver, BC facility is presold to 70 percent of its capacity. In California, they well underway with their 1st 100,000 kg facility, and they plan to propagate the first plants during the third quarter. California is infested with pesticide laden cannabis, 85-90 percent of it. New state rules require stringent testing and pesticide/ fungus free so it is anticipated that a huge shortage will be prevalent by the third quarter. Although unannounced yet, it looks as though the Cathedral City facility will be sold out of the phase 1 quantity of 65,000 kg, 50 percent of which is high margin extracts which they will be producing at their new 500/lb per day facility down the road. Listening to the CEO interview yesterday, with the recent moves by Congress towards descheduling cannabis, they are now aggressively pursuing acquisition targets in the state. And finally, they have the least amount of share dilution I have seen to date. The California facility is leased to a huge real estate development firm, whom the CEO is on the Sunniva board of directors. The Canadian facility will also be predominantly financed with a tier 1 bank as opposed to share dilution via cheap stock share purchased (bought financing). Sunniva initial IPO was only in January and their first financial release as a public company is this Tuesday. GLTA
<< Previous
Bullboard Posts
Next >>